Penumbra, Inc Net Income (Loss) Available to Common Stockholders, Diluted
Penumbra, Inc (PEN) reported Net Income (Loss) Available to Common Stockholders, Diluted of -$1.56 million for the 3-month period ending 2017-06-30, per its 10-Q filed 2017-08-08.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2017-08-08
- Penumbra, Inc net income (loss) available to common stockholders, diluted for the quarter ending 2017-06-30 was -$1.56M, a 151.71% decline year-over-year.
- Penumbra, Inc net income (loss) available to common stockholders, diluted for the quarter ending 2017-03-31 was -$3.11M, a 235.57% decline year-over-year.
- Penumbra, Inc net income (loss) available to common stockholders, diluted for the quarter ending 2016-12-31 was $14.96M, a 1545.21% increase year-over-year.
- Penumbra, Inc net income (loss) available to common stockholders, diluted for the quarter ending 2016-09-30 was -$1.11M, a 500.72% decline year-over-year.
- Penumbra, Inc net income (loss) available to common stockholders, diluted for fiscal 2016 was $14.81M, a 1266.61% increase from fiscal 2015.
- Penumbra, Inc net income (loss) available to common stockholders, diluted for fiscal 2015 was $1.08M.
- Penumbra, Inc net income (loss) available to common stockholders, diluted for fiscal 2014 was -$833.00K, a 193.91% decline from fiscal 2013.
- Penumbra, Inc net income (loss) available to common stockholders, diluted for fiscal 2013 was $887.00K.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 3 month as first filed | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month |
|---|---|---|---|---|---|
| 2017-06-30 | -$1.56M 10-Q · filed 2017-08-08 | -$4.66M derived: sum of 2 quarters · filed 2017-08-08 | $10.29M derived: sum of 3 quarters · filed 2017-08-08 | $9.19M derived: sum of 4 quarters · filed 2017-08-08 | |
| 2017-03-31 | -$3.11M 10-Q · filed 2017-05-09 | $11.85M derived: sum of 2 quarters · filed 2017-05-09 | $10.74M derived: sum of 3 quarters · filed 2017-05-09 | $13.76M derived: sum of 4 quarters · filed 2017-08-08 | |
| 2016-12-31 | $14.96M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $13.85M derived: sum of 2 quarters · filed 2017-02-28 | $16.86M derived: sum of 3 quarters · filed 2017-08-08 | $14.81M 10-K · filed 2017-02-28 | |
| 2016-09-30 | -$1.11M 10-Q · filed 2016-11-03 | $1.91M derived: sum of 2 quarters · filed 2017-08-08 | -$141.00K 10-Q · filed 2016-11-03 | $5.11M derived: sum of 4 quarters · filed 2017-08-08 | |
| 2016-06-30 | $3.01M 10-Q · filed 2017-08-08 | $185.00K 10-Q · filed 2016-08-09 | $965.00K 10-Q · filed 2016-08-09 | $6.21M derived: sum of 3 quarters · filed 2017-08-08 | $6.49M derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-03-31 | $2.29M 10-Q · filed 2017-05-09 | $780.00K 10-Q · filed 2016-05-09 | $3.20M derived: sum of 2 quarters · filed 2017-05-09 | $3.48M derived: sum of 3 quarters · filed 2017-05-09 | $2.92M derived: sum of 4 quarters · filed 2017-05-09 |
| 2015-12-31 | $909.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $1.19M derived: sum of 2 quarters · filed 2017-02-28 | $632.00K derived: sum of 3 quarters · filed 2017-02-28 | $1.08M 10-K · filed 2017-02-28 | |
| 2015-09-30 | $276.00K 10-Q · filed 2016-11-03 | -$277.00K derived: sum of 2 quarters · filed 2016-11-03 | $175.00K 10-Q · filed 2016-11-03 | $326.00K derived: sum of 4 quarters · filed 2017-02-28 | |
| 2015-06-30 | -$553.00K 10-Q · filed 2016-08-09 | -$34.00K 10-Q · filed 2016-08-09 | $50.00K derived: sum of 3 quarters · filed 2017-02-28 | -$1.14M derived: sum of 4 quarters · filed 2017-02-28 | |
| 2015-03-31 | $503.00K 10-Q · filed 2016-05-09 | $603.00K derived: sum of 2 quarters · filed 2017-02-28 | -$589.00K derived: sum of 3 quarters · filed 2017-02-28 | ||
| 2014-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | -$1.09M derived: sum of 2 quarters · filed 2017-02-28 | -$833.00K 10-K · filed 2017-02-28 | ||
| 2014-09-30 | -$1.19M 10-Q · filed 2015-11-12 | -$933.00K 10-Q · filed 2015-11-12 | |||
| 2013-12-31 | $887.00K 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |